Able Labs Awaits Bankruptcy Court Approval For Sale Of Assets To Aurobindo
This article was originally published in The Pink Sheet Daily
Trenton, N.J. federal bankruptcy court judge will hear argument on Oct. 19; the deal is contingent upon several items.
You may also be interested in...
Able plans to sell its business and assets rather than pursue full resubmission of its ANDAs.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.